|

HF158K1 / 1.4 g lipid dose Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Infusion

Pipeline

Phase 1: 1

Top Sponsors

  • HighField Biopharmaceuticals Corporation1

Indications

  • Solid Tumors, Adult1
  • Cancer1

Dallas, Texas1 trial

HF158K1 in Patients With HER-2 Expressing Advanced Solid Tumors

Mary Crowley Cancer Research

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.